Literature DB >> 11004669

Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer.

A M Hanby1, D P Kelsell, H W Potts, C E Gillett, D T Bishop, N K Spurr, D M Barnes.   

Abstract

Germline mutations in the breast cancer-associated genes BRCA1 and BRCA2 confer a lifetime risk of malignancy. Distinctive morphological features have been attributed to these familial tumours; however, in sporadic breast cancer, the inter-relationship between loss of heterozygosity (LOH) of these loci and tumour morphology remains to be fully elucidated. We studied a series of 120 sporadic breast carcinomas using microsatellite markers to identify LOH of BRCA1, BRCA2, p53 and PTEN. The associations between loss at each of the loci were examined and related to tumour morphology. LOH of the 4 loci did not occur independently; there were highly significant associations between LOH of BRCA1 and both BRCA2 (p < 0.001) and p53 (p < 0.001). LOH at all 4 loci was significantly associated with a high degree of nuclear pleomorphism. Tumours with LOH of BRCA1 also had high mitotic indices, few tubules and a paucity of DCIS, all of which are morphological features similar to those described for familial cases. Following Bonferroni's correction for multiple tests, we found that the tumours with LOH of BRCA1 were still significantly associated with a high mitotic index (p = 0.0006) and a high degree of nuclear pleomorphism (p = 0.001). Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004669

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil.

Authors:  S C L Santos; L R Cavalli; I J Cavalli; R S Lima; B R Haddad; E M S F Ribeiro
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.

Authors:  Mari J Tokita; Chun-An Chen; David Chitayat; Ellen Macnamara; Jill A Rosenfeld; Neil Hanchard; Andrea M Lewis; Chester W Brown; Ronit Marom; Yunru Shao; Danica Novacic; Lynne Wolfe; Colleen Wahl; Cynthia J Tifft; Camilo Toro; Jonathan A Bernstein; Caitlin L Hale; Julia Silver; Louanne Hudgins; Amitha Ananth; Andrea Hanson-Kahn; Shirley Shuster; Pilar L Magoulas; Vipulkumar N Patel; Wenmiao Zhu; Stella M Chen; Yanjun Jiang; Pengfei Liu; Christine M Eng; Dominyka Batkovskyte; Alberto di Ronza; Marco Sardiello; Brendan H Lee; Christian P Schaaf; Yaping Yang; Xia Wang
Journal:  Am J Hum Genet       Date:  2018-06-28       Impact factor: 11.025

3.  BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma.

Authors:  Nathan D Seligson; Esko A Kautto; Edward N Passen; Colin Stets; Amanda E Toland; Sherri Z Millis; Christian F Meyer; John L Hays; James L Chen
Journal:  Oncologist       Date:  2018-12-12

4.  Molecular cytogenetic investigations of synchronous bilateral breast cancer.

Authors:  K Agelopoulos; N Tidow; E Korsching; R Voss; B Hinrichs; B Brandt; W Boecker; H Buerger
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

5.  Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Brad Love; Darrell L Ellsworth; Craig D Shriver
Journal:  Pathol Oncol Res       Date:  2009-02-05       Impact factor: 3.201

6.  Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing.

Authors:  Qi Zhao; Ewen F Kirkness; Otavia L Caballero; Pedro A Galante; Raphael B Parmigiani; Lee Edsall; Samantha Kuan; Zhen Ye; Samuel Levy; Ana Tereza R Vasconcelos; Bing Ren; Sandro J de Souza; Anamaria A Camargo; Andrew J G Simpson; Robert L Strausberg
Journal:  Genome Biol       Date:  2010-11-25       Impact factor: 13.583

7.  Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers.

Authors:  C L Clarke; J Sandle; A A Jones; A Sofronis; N R Patani; S R Lakhani
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

8.  Genetic instability in the RAD51 and BRCA1 regions in breast cancer.

Authors:  Maria Nowacka-Zawisza; Magdalena Bryś; Hanna Romanowicz-Makowska; Andrzej Kulig; Wanda M Krajewska
Journal:  Cell Mol Biol Lett       Date:  2006-12-18       Impact factor: 5.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.